doi: 10.1038/sj.jhh.1001416 Vanderah TW (2024): Cholinoceptor-Blocking Drugs
As small-molecule compounds such as orforglipron hailed as a product for the masses move swiftly towards widespread clinical use, it will be crucial to define their long-term effects. Food and beverage needs to stay abreast of developments like this to not only support users in a different way, but to be ready for the vast numbers of people that the drugs may extend to
Semaglutide is a GLP-1 receptor agonist that supports appetite regulation and glucose control, contributing to weight management
RomeoSKozlitinaJXingCPertsemlidisACoxDPennacchioLAet al
The cardiovascular benefits emerge from both direct drug effects and weight loss synergy
The official label lists common adverse reactions such as nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, bloating, belching, and reflux